State of Research
Quality of Conclusions
TBD Papers studying this directly
TBD Companies working on this
Access all our research
Become a free member now to get unlimited access.
Receive our weekly update on the latest psychedelic research, make (private) notes on pages, and download our reports.
Our vision is that psychedelics can be used worldwide to better the lives of as many as 450 million people who suffer from mental health problems. Our information hopes to make that vision come to life just a little faster.
Eating Disorders Research
Here will be a narrative, readable, summary of the research.
In our literature study we came across the following studies of note. Browse the meta, review, commentary articles for an overview. Check out the individual studies for specific experiments and observations.
Psychedelics and Health Behavior Change
This review (2021) explores the prospects of psychedelic substances as facilitators of behavioral change that promote a healthy lifestyle concerning diet, exercise, and substance abuse, through psychological mechanisms such as the relaxation of prior beliefs. The authors emphasize that self-determination, confidence, and interconnectedness as useful concepts to understand how individuals derive positive perspectives and internal motivation from a well-integrated psychedelic experience. It is noted that psychedelic substances should not replace, but augment, prior commitments, as they highlight their integration within the context of therapeutic models, such as Cognitive Behavioral Therapy or Acceptance and Commitment Therapy.
The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD
2020 | Brewerton, T. D., Lafrance, A., Mithoefer, M. C.
This hypothesis paper (2020) makes the case for treating eating disorders (EDs) comorbid with posttraumatic stress disorder (PTSD).
Ketamine Use for Suicidal Ideation in the General Hospital: Case Report and Short Review
2018| Baup, E., Lefebvre, D., Lemogne, C., Limosin, F., Passeron, A., Rieutord, M., Seigneurie, A. S., Thauvin, I., Vulser, C., Vulser, H.
This case report (n=1) describes an anorexic patient who was treated with repeated dose ketamine (0.5mg/kg, 20mg) following a suicide attempt and persevering suicidal ideation (SI). Although the first dose had little effect, the second dose administered 2 weeks after led to a dramatic decrease in depression, hopelessness, and suicidal ideation.
An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders
2018| Files, N., Fletcher, J., Lafrance, A., Loizaga-Velder, A., Renelli, M., Tupper, K. W.
This interview study (n=13) suggests that ayahuasca could be an effective therapeutic tool for eating disorders (EDs). Themes identified were 1) rapid reduction in ED thoughts and symptoms, 2) healing at the perceived root cause, 3) help process painful feelings and memories, 4) greater self-love and self-acceptance, and 5) activated spiritual elements of healing.
Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders
2017| Files, N., Fletcher, J., Lafrance, A., Loizaga-Velder, A., Renelli, M., Tupper, K. W.
This interview study (n=16) suggests that ayahuasca may hold promise as a treatment for eating disorders (EDs). The interviewees (who used ayahuasca) indicated shifts in body perception, reduction or cessation of ED and mental health symptoms.
Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder
2020| Carhart-Harris, R. L., Kettner, H., Spriggs, M. J.
This prospective survey study (n=28) found significant improvements on depression and well-being scores after psychedelics use for those with eating disorders (EDs).
This section compares the research with psychedelics to other therapies, medicines, or treatments.
This section highlights the various measures used and their use in research.
Who are the top researches in this area, the ones who have done the groundbreaking research.
What do we not know at this time? Where are the gaps in our knowledge and are we closing it?
The companies that are actively engaged in researching this topic or (planning to) provide therapy focussed on this topic.
This section highlights everything done outside of academia, from popular press to books and non academic research.